Adocia Adds $200M To Arbitration Demand Against Eli Lilly
French biopharmaceutical company Adocia SA is seeking over $200 million more in damages from Eli Lilly and Co. in arbitration over an abandoned partnership on the diabetes treatment BioChaperone Lispro, adding...To view the full article, register now.
Already a subscriber? Click here to view full article